Direct Mouse Genotyping Kit Plus for Macrophage Studies

Mouse models of inflammation, cancer, and macrophage biology often depend on accurate identification of several alleles before any tissue collection begins. A missed reporter allele, incomplete knockout, or incorrect breeding assignment can compromise downstream flow cytometry, immunofluorescence, and transcriptomic interpretation. The Direct Mouse Genotyping Kit Plus addresses this front-end bottleneck by combining tissue lysis, neutralization, and direct PCR in a streamlined workflow. APExBIO supplies the kit for research use only; it is not intended for diagnostic or medical applications.

Setup and principle overview

This mouse genomic DNA extraction and PCR amplification kit uses an optimized lysis buffer and balance-buffer system to release genomic DNA from mouse tissue without a separate purification, precipitation, or column-transfer step. After neutralization, a portion of the lysate can be added directly to PCR. That design is useful when a laboratory must genotype many animals rapidly or preserve purified-DNA workflows for assays that genuinely require cleaner nucleic acid.

The included 2X HyperFusion™ high-fidelity PCR master mix with dye reagents simplifies reaction assembly and supports direct loading of amplified products onto an agarose gel. In routine applications, the same workflow can support a mouse genotyping assay for wild-type, heterozygous, and homozygous animals; transgene detection in mice; gene knockout validation; and animal colony genetic screening. The dye is operationally convenient, but it does not replace a DNA ladder, positive control, or appropriate negative control.

For macrophage studies, genotyping is best treated as an identity and experimental-eligibility checkpoint. It can confirm that a mouse carries a reporter, conditional allele, or lineage-tracing component, but it cannot prove that a macrophage population has a particular origin, phenotype, or epigenetic state. Those biological conclusions require the tissue-level assays described below.

Key Innovation from the Reference Study

The reference study, Alternations in inflammatory macrophage niche drive phenotypic and functional plasticity of Kupffer cells, examined how macrophage populations behave during liver metastasis. Using multiple lineage-tracing models, a proliferation-recording system, a Kupffer-cell tracing model in a monocyte-deficient background, flow cytometry, immunofluorescence, and CITE-seq, the investigators showed that monocyte-derived macrophages were a major source of liver metastasis-associated macrophages. However, removing that source produced only a marginal reduction in the macrophage pool because local macrophage proliferation and Kupffer-cell infiltration could replenish the niche.

The study also reported that infiltrating Kupffer cells underwent transient proliferation and substantial phenotypic and functional alteration through epigenetic reprogramming. In the flow-cytometry comparisons summarized in the article, cohort sizes included five MC38-model mice, five E0771-model mice, and six mice in the hepatocellular carcinoma model; these values are reported in the Nature Communications reference study. The findings are important for assay design because a marker-positive cell population should not automatically be interpreted as a single stable lineage.

Practically, this work favors a layered experimental strategy. First, genotype the reporter and driver alleles before induction or tumor implantation. Second, confirm the expected recombination or allele-specific event with an assay designed for that event rather than relying only on the presence of a transgene. Third, pair genotype data with flow cytometry, tissue imaging, and, when appropriate, transcriptomic or chromatin-level measurements. The Direct Mouse Genotyping Kit Plus can accelerate the first and second checkpoints, while it should not be presented as a substitute for lineage tracing or cell-state profiling. The reference study does not report use of this commercial kit, so this is a workflow translation rather than a claim of direct product validation in that publication.

Step-by-step workflow for reliable colony decisions

1. Plan the genotype before sampling

Define the alleles that must be distinguished and the expected amplicon sizes before collecting tissue. For a conditional knockout, plan separate primer sets for the wild-type and modified alleles, and add a recombination-specific assay if the biological question concerns tissue-specific deletion. For a reporter model, include an internal control amplicon where possible. A small ear or tail sample is usually sufficient for colony decisions, while tissue collected for phenotype analysis should be kept separate to avoid cross-contamination.

2. Lyse tissue and neutralize the lysate

Use the kit lysis buffer and Proteinase K according to the current product instructions. After digestion, apply the balance buffer as directed and mix thoroughly. The objective is not to produce a purified DNA solution; it is to generate a neutralized lysate compatible with the high-fidelity PCR mix. Excess tissue, incomplete digestion, or inadequate neutralization can increase inhibition, so begin with modest tissue input when establishing the assay.

3. Build PCR with controls

Prepare reactions using the supplied 2X master mix, allele-specific primers, and a measured volume of neutralized lysate. Include a known wild-type sample, a known positive allele sample, and a no-template control on every new primer set or plate. For high-throughput animal colony screening, arrange samples so that control wells are distributed across the plate rather than placed in only one corner.

4. Resolve and interpret products

The dye reagents in the PCR master mix with dye reagents allow amplified products to move directly toward gel analysis, reducing post-PCR handling. Run an agarose gel with a suitable size ladder and interpret bands against the predicted allele architecture. A single band may represent a homozygous genotype, but it may also reflect allele dropout; genotype calls should therefore be based on the complete control pattern and, for critical lines, a second independent assay.

5. Record genotype and biological context

Store the genotype call alongside sex, age, treatment group, tissue source, and experimental batch. In macrophage experiments, record whether the sample is intended for resident Kupffer-cell analysis, monocyte-derived macrophage analysis, or both. This prevents a technically correct genotype from being overinterpreted as evidence of a particular inflammatory cell state.

Protocol Parameters

These are practical starting conditions for assay development, not universal product specifications. Confirm exact lysis, balance-buffer, and cycling instructions in the current kit protocol and optimize each primer pair.

• Tissue input: Start with 1–2 mg of ear or tail tissue in the recommended lysis volume; test 1 mg and 2 mg in parallel if inhibition is suspected.
• Lysis screen: Compare 30, 45, and 60 minutes at 55 °C with Proteinase K, then apply the balance buffer using the manufacturer-directed volume and mixing step.
• Template titration: Test 0.5 µL, 1 µL, and 2 µL of neutralized lysate in a 25 µL PCR reaction; use the lowest volume that produces a specific band.
• Primer starting point: Begin with 0.2 µM of each primer in the final reaction and evaluate an annealing-temperature range of 58–65 °C when primer design permits.
• Cycling screen: A reasonable high-fidelity starting program is 98 °C for 30 seconds, followed by 30–35 cycles of 98 °C for 10 seconds, annealing for 15 seconds, and 72 °C for 20–30 seconds per kilobase, with a 72 °C final extension for 2 minutes.
• Gel check: Use 1.5–2% agarose, load 5–10 µL of PCR product, and run at 90–120 V for 20–40 minutes, adjusting voltage and time to the expected amplicon size.
• Storage: Keep lysis and balance buffers at 4 °C. The product information lists the master mix and Proteinase K as stable at −20 °C for 1–2 years when stored appropriately; minimize repeated freeze-thaw cycles.

Advanced applications and comparative advantages

The direct-lysate format is especially useful for breeding programs that combine a driver allele, a reporter allele, and a floxed or disrupted target. Instead of purifying DNA from every animal, a laboratory can triage samples by PCR and reserve more intensive confirmation for selected breeders. This supports transgene detection in mice and gene knockout validation without implying that every allele requires the same primer architecture.

For liver metastasis studies, genotype confirmation can occur before tumor challenge, macrophage depletion, or tissue harvest. That reduces the risk of investing in downstream single-cell or imaging experiments with an incorrectly configured animal. The product’s high-fidelity master mix may also be advantageous when allele discrimination depends on a defined amplicon, although specificity still depends primarily on primer design, template quality, and cycling conditions.

A previously published purification-free genotyping resource complements this article by emphasizing the same direct-lysate concept and its workflow rationale. A separate high-throughput genotyping resource extends the discussion toward colony-scale implementation. These resources complement rather than replace the product instructions, which should govern reagent volumes and validated cycling conditions.

Why this cross-domain matters, maturity, and limitations

Genotyping and macrophage biology answer different questions. The first establishes whether an animal is eligible for an experiment; the second determines which cells occupy a tissue niche and how their function changes. The reference study demonstrates that macrophage populations can be replenished through more than one route, so a genetic label must be interpreted with lineage and state measurements. This cross-domain workflow is mature for eligibility screening but remains limited for causal cell-attribution claims: direct PCR cannot distinguish infiltrating from resident macrophages, measure epigenetic reprogramming, or establish functional immunosuppression.

Troubleshooting and optimization tips

No band in sample and positive control

Check master-mix storage, primer addition, thermal-cycler programming, and gel staining first. If the positive control also fails, prepare a fresh reaction and verify that the 2X mix was fully thawed and mixed without vigorous foaming. Because the workflow uses crude lysate, test a smaller template volume or a more complete tissue digestion before redesigning the assay.

No band in one sample but valid controls

Possible causes include insufficient tissue, incomplete lysis, allele dropout, or an absent allele. Re-amplify with 0.5 µL rather than 2 µL lysate if inhibition is likely, and run an internal control amplicon. For a conditional knockout, distinguish failure of DNA recovery from failure of recombination by testing a constitutive genomic target and a recombination-specific primer pair separately.

Smearing or weak, diffuse amplification

Reduce tissue input, shorten the lysate volume added to PCR, and confirm that the balance-buffer step was completed. Excess genomic material and residual lysis components can inhibit polymerase activity or produce nonspecific products. On the gel, avoid overloading wells and verify that the agarose percentage matches the expected product size.

Multiple bands or unexpected sizes

Raise the annealing temperature in 2 °C increments, reduce cycle number, or perform a short gradient across 58–65 °C. Confirm primer orientation and inspect the allele map for repeated sequences or unintended primer binding. A three-primer assay can help distinguish wild-type and targeted alleles, but it should be validated with known genotypes before being used for colony decisions.

Inconsistent results across plates

Use a master mix for the common reaction components, change tips between samples, and include controls on every plate. Keep 4 °C buffers cold during the working day and return the −20 °C components promptly after use. If bands vary with operator or batch, compare a fixed positive-control lysate across plates before changing primer concentrations.

Future outlook

The reference study supports a more cautious view of macrophage lineage and encourages simultaneous attention to monocyte recruitment and macrophage proliferation. In future experiments, rapid genotype confirmation can make complex tracing designs more reproducible by ensuring that driver, reporter, and target alleles are verified before phenotype measurements begin. The central limitation remains unchanged: the kit accelerates genomic eligibility and allele confirmation, while the biological interpretation of Kupffer-cell plasticity still depends on integrated lineage tracing, imaging, flow cytometry, and molecular profiling.